1,536 Shares in UnitedHealth Group Incorporated $UNH Acquired by Leo Wealth LLC

Posted by Geri Gentry on Oct 28th, 2026

Leo Wealth LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,536 shares of the healthcare conglomerate’s stock, valued at approximately $564,000.

Several other large investors have also modified their holdings of UNH. Holos Integrated Wealth LLC grew its stake in UnitedHealth Group by 47.1% in the 3rd quarter. Holos Integrated Wealth LLC now owns 125 shares of the healthcare conglomerate’s stock valued at $51,000 after buying an additional 40 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its position in UnitedHealth Group by 13.4% during the 3rd quarter. Kingswood Wealth Advisors LLC now owns 10,525 shares of the healthcare conglomerate’s stock worth $3,863,000 after acquiring an additional 1,242 shares during the last quarter. Paladin Wealth LLC boosted its holdings in UnitedHealth Group by 6.8% during the third quarter. Paladin Wealth LLC now owns 3,011 shares of the healthcare conglomerate’s stock valued at $1,105,000 after acquiring an additional 191 shares during the period. Winter & Associates Inc. grew its position in shares of UnitedHealth Group by 7.1% in the third quarter. Winter & Associates Inc. now owns 1,111 shares of the healthcare conglomerate’s stock valued at $408,000 after purchasing an additional 74 shares during the last quarter. Finally, Provident Investment Management Inc. increased its stake in shares of UnitedHealth Group by 3.6% in the third quarter. Provident Investment Management Inc. now owns 1,420 shares of the healthcare conglomerate’s stock worth $521,000 after purchasing an additional 49 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $410.72 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The stock has a fifty day moving average of $389.07 and a 200-day moving average of $361.44.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. The company’s revenue was down .4% compared to the same quarter last year. During the same period last year, the company earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on UNH shares. New Street Research set a $402.00 price objective on UnitedHealth Group in a research report on Friday, October 9th. Raymond James Financial reaffirmed an “outperform” rating and issued a $450.00 target price on shares of UnitedHealth Group in a report on Thursday, October 15th. Barclays cut their price target on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a report on Wednesday, October 14th. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $463.93.

View Our Latest Research Report on UNH

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.